WHO Bows To Criticism, Creates Open Bird Flu Database
This article was originally published in PharmAsia News
The World Health Organization has acceded to demands by Southeast Asian nations and established a public database of information to follow spreads of the strains of the bird flu virus. In the past, some nations refused to provide the United Nations agency with samples of their local H5N1 strains for fear they would be used by multinational pharmaceutical companies to produce a vaccine too expensive for poor countries. A WHO official acknowledged it was responding to a demand for transparency in its attempt to prevent a global pandemic of the flu. (Click here for more - may require a subscription
You may also be interested in...
Merck’s third quarter beat analyst consensus and the company raised its guidance. The COVID-19-battered vaccines business began to improve but Gardasil’s recovery was slower than expected.
Given concerns about completing Phase III trials, advisory committee member asks whether US FDA has considered ‘the possibility of an expanded access protocol,’ but agency official points to added complexity that comes with the pathway; bioethics experts talk to the Pink Sheet about pros and cons of expanded access vs. EUA pathways.
From the rise of DTC to the shadow of Caronia, Abrams, the long-time head of the Office of Prescription Drug Promotion, monitored dramatic changes in the pharmaceutical marketplace and regulatory environment. He retired from FDA on 23 October after a tenure marked as much by careful research projects and copious guidances as it was by promotional and legal upheavals.